Li SL - Search Results

1

Nimotuzumab suppresses epithelial-mesenchymal transition and enhances apoptosis in low-dose UV-C treated salivary adenoid cystic carcinoma cell lines in vitro.

Jiang Y, Ge XY, Liu SM, Zheng L, Huang MW, Shi Y, Fu J, Zhang JG, Li SL. Jiang Y, et al. Among authors: li sl. Anticancer Drugs. 2014 Oct;25(9):1052-60. doi: 10.1097/CAD.0000000000000139. Anticancer Drugs. 2014. PMID: 25035960

2

[An antimetastatic study of Arg-Asp (RD) on salivary adenoid cystic carcinoma in vivo].

Li F, Yu G, Li S, Peng S, Fu J, Wu D. Li F, et al. Zhonghua Kou Qiang Yi Xue Za Zhi. 2002 Mar;37(2):87-9. Zhonghua Kou Qiang Yi Xue Za Zhi. 2002. PMID: 12475414 Chinese.

3

The inhibitory effect of a novel organoselenium compound BBSKE on the tongue cancer Tca8113 in vitro and in vivo.

Xing F, Li S, Ge X, Wang C, Zeng H, Li D, Dong L. Xing F, et al. Oral Oncol. 2008 Oct;44(10):963-9. doi: 10.1016/j.oraloncology.2007.12.001. Epub 2008 Feb 20. Oral Oncol. 2008. PMID: 18282784

4

Epiregulin promotes migration and invasion of salivary adenoid cystic carcinoma cell line SACC-83 through activation of ERK and Akt.

Hu K, Li SL, Gan YH, Wang CY, Yu GY. Hu K, et al. Among authors: li sl. Oral Oncol. 2009 Feb;45(2):156-63. doi: 10.1016/j.oraloncology.2008.04.009. Epub 2008 Jul 11. Oral Oncol. 2009. PMID: 18620900

5

Relationship of activated extracellular signal-regulated kinase 1/2 with lung metastasis in salivary adenoid cystic carcinoma.

Hu K, Gan YH, Li SL, Gao Y, Wu DC, Wang CY, Yu GY. Hu K, et al. Among authors: li sl. Oncol Rep. 2009 Jan;21(1):137-43. Oncol Rep. 2009. PMID: 19082454

6

Quinacrine enhances cisplatin-induced cytotoxicity in four cancer cell lines.

Wang Y, Bi Q, Dong L, Li X, Ge X, Zhang X, Fu J, Wu D, Li S. Wang Y, et al. Chemotherapy. 2010;56(2):127-34. doi: 10.1159/000313525. Epub 2010 Apr 20. Chemotherapy. 2010. PMID: 20407239

7

Activation of c-Jun N-terminal kinase is required for mevastatin-induced apoptosis of salivary adenoid cystic carcinoma cells.

Zhang S, Wang XL, Gan YH, Li SL. Zhang S, et al. Among authors: li sl. Anticancer Drugs. 2010 Aug;21(7):678-86. Anticancer Drugs. 2010. PMID: 20629200

8

Investigation of the efficacy of a bevacizumab-cetuximab-cisplatin regimen in treating head and neck squamous cell carcinoma in mice.

Wang Y, Dong L, Bi Q, Li X, Wu D, Ge X, Zhang X, Fu J, Zhang C, Wang C, Li S. Wang Y, et al. Target Oncol. 2010 Dec;5(4):237-43. doi: 10.1007/s11523-010-0164-3. Epub 2010 Nov 18. Target Oncol. 2010. PMID: 21086056

9

Beyond antiangiogenesis: intratumorally injected bevacizumab plays a cisplatin-sensitizing role in squamous cell carcinomas in mice.

Wang Y, Dong L, Bi Q, Ge X, Zhang X, Wu D, Fu J, Zhang C, Wang C, Li S. Wang Y, et al. Chemotherapy. 2011;57(3):244-52. doi: 10.1159/000326485. Epub 2011 May 19. Chemotherapy. 2011. PMID: 21597289

10

An experimental study of the management of severe keratoconjunctivitis sicca with autologous reduced-sized submandibular gland transplantation.

Ge XY, Yu GY, Fu J, Wu DC, Zhang XX, Wang YX, Li SL. Ge XY, et al. Among authors: li sl. Br J Oral Maxillofac Surg. 2012 Sep;50(6):562-6. doi: 10.1016/j.bjoms.2011.10.004. Epub 2011 Nov 1. Br J Oral Maxillofac Surg. 2012. PMID: 22051179

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,665 results

Search Page

Filters